Sakar Healthcare initiates process of business expansion with anti-cancer drugs

11 Jun 2019 Evaluate

Sakar Healthcare has initiated the process of business expansion with anti-cancer (oncology) drugs. The project has been perceived and articulated to get operational by 2021. The market dynamics, encouraging growth opportunity and in-house competency have been the decisive factors to opt for this therapeutic class of drugs.

The team including up-to-date scientists and well experienced subject matter experts has been appointed to give a proper shape to the plans along with suitable inputs from Institute of Chemical Technology (ICT), Mumbai. The plant layout following international regulatory standards and fitting in to the procured land is already in place to initiate the site development and construction of building work. The project feasibility and Techno Economic Viability Study have been duly conducted by Gujarat Industrial and Technical Consultancy Organisation (GITCO).

Sakar Healthcare is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. The company manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.